In-hospital mortality for community acquired pneumonia and evaluation according to national diagnosis and treatment guidelines

N. Kiral, A. Fidan, I. Erdem, A. Eren, B. Çaglayan (Istanbul, Turkey)

Source: Annual Congress 2004 - Community acquired pneumonia
Session: Community acquired pneumonia
Session type: Thematic Poster Session
Number: 1185
Disease area: Respiratory infections

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
N. Kiral, A. Fidan, I. Erdem, A. Eren, B. Çaglayan (Istanbul, Turkey). In-hospital mortality for community acquired pneumonia and evaluation according to national diagnosis and treatment guidelines. Eur Respir J 2004; 24: Suppl. 48, 1185

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Economic evaluation of adherence to treatment guidelines in nonintensive care pneumonia
Source: Eur Respir J 2007; 29: 751-756
Year: 2007



Community acquired pneumonia in the emergency department: Comparison of clinical indication to in-hospital treatment and severity scales predicting mortality
Source: Annual Congress 2012 - Respiratory infections: prognosis and outcome
Year: 2012

Clinical features associated with mortality in patients with community acquired pneumonia requiring hospitalisation
Source: Eur Respir J 2004; 24: Suppl. 48, 414s
Year: 2004

Antibiotic therapy of community-acquired pneumonia in the hospital setting: national guidelines and real clinical practice.
Source: International Congress 2017 – COPD management
Year: 2017

The impact of national recommendations on antibiotic treatment of community acquired pneumonia. Do pediatricians follow the national guidelines?
Source: International Congress 2017 – Pulmonary infection and inflammation
Year: 2017


The impact of adherence to guidelines for hospitalized community-acquired pneumonia on health outcomes and mortality: A retrospective cohort study
Source: International Congress 2015 – Pneumonia: determinants of clinical outcomes and potential strategies to improve its management
Year: 2015


Can improved outcomes be achieved when patients with community acquired pneumonia are managed in accordance with the national guidelines?
Source: Annual Congress 2008 - Treatment and outcome in hospitalised patients with community-acquired pneumonia
Year: 2008

Comparison of prospective scores for predicting mortality and hospital admission in hospitalised patients and out-patients with CAP
Source: Annual Congress 2005 - Community-acquired pneumonia: clinical approaches
Year: 2005


Guideline-concordant therapy and outcomes in healthcare-associated pneumonia
Source: Eur Respir J 2011; 38: 878-887
Year: 2011



Implementation of ERS guidelines for the management of adult community-acquired pneumonia in a primary care hospital
Source: Eur Respir J 2001; 18: Suppl. 33, 503s
Year: 2001

Cost minimization for community-acquired pneumonia management in Belarussian hospital from implementation of clinical guidelines
Source: Eur Respir J 2005; 26: Suppl. 49, 258s
Year: 2005

Scores of community acquired pneumonia for predicting intensive care admission and mortality
Source: Respiratory Failure and Mechanical Ventilation Conference 2020
Year: 2020



Implementation of severity guided antibiotic treatment according to Dutch guidelines in hospitalized patients with community-acquired pneumonia (CAP) included in a clinical trial
Source: Annual Congress 2011 - Antimicrobial treatment and resistance in lower respiratory tract infections
Year: 2011

Assessment of prognostic scores for 30-day mortality prediction in hospitalised patients with health care associated pneumonia (HCAP)
Source: Annual Congress 2010 - The prognosis of community-acquired pneumonia: old and new markers of severity
Year: 2010

Community acquired pneumonia guidelines: not only treatment indications
Source: Annual Congress 2004 - PG22 - New perspectives in pneumonia treatment and prophylaxis
Year: 2004

A worldwide perspective of the level of compliance with guidelines in hospitalized patients with community-acquired pneumonia: results from the CAPO cohort international study
Source: Annual Congress 2008 - Treatment and outcome in hospitalised patients with community-acquired pneumonia
Year: 2008


Use of ATS/IDSA severe pneumonia minor criteria to improve emergency department patient disposition: effect on 30-day mortality and resource utilization
Source: Virtual Congress 2020 – Clinical challenges in pneumonia
Year: 2020


Management of community acquired pneumonia in UK hospitals: a survey of the availability of local guidelines and severity assessment tools
Source: Annual Congress 2007 - Antibiotic treatment in community-acquired pneumonia
Year: 2007


Outcomes of patients admitted with community acquired pneumonia following the introduction of new hospital guidelines in a district general hospital
Source: Annual Congress 2009 - Assessment of severity in respiratory infections: severity scales and biomarkers
Year: 2009

Studying the association between mortality in patients requiring hospital admission for Community Acquired Pneumonia and pre-hospital antibiotic treatment in primary care
Source: International Congress 2017 – Discussion of vaccines, biomarkers and risk factors analysis  
Year: 2017